We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Reducing Chloride in IV Fluids May Improve Renal Outcomes

By HospiMedica International staff writers
Posted on 29 Oct 2012
A new study suggests that chloride-restrictive intravenous (IV) fluid strategy could reduce acute kidney injury (AKI) in the intensive care unit (ICU).

Researchers at Austin Hospital (Melbourne, VIC, Australia) conducted a prospective study of 1,533 patients (773 intervention patients, 760 controls) admitted consecutively to the ICU. More...
During the control period, patients received standard IV fluids; after a 6-month phase-out period, any use of chloride-rich IV fluids (0.9% saline, 4% succinylated gelatin solution, or 4% albumin solution) was restricted to attending specialist approval. Patients instead received a lactated solution (Hartmann solution), a balanced solution (Plasma-Lyte 148), and chloride-poor 20% albumin. The primary outcome measures included peak creatinine level and incidence of AKI. Other outcomes included the need for renal replacement therapy (RRT), length of stay in ICU and hospital, and survival.

The results showed that the change in IV chloride levels was associated with a significantly smaller mean serum creatinine level increase (14.8 versus 22.6 µmol/L), a lower rate of AKI as defined by to the risk, injury, failure, loss, end-stage (RIFLE) classification (8.4% versus 14%), and a lower rate of renal replacement therapy use (6.3% versus 10%). After adjustment for potential confounders, the rates of AKI and RRT were both a relative 48% lower during the intervention phase. There was no difference in mortality between the control and intervention periods. The study was published in the October 17, 2012, issue of the Journal of the American Medical Association (JAMA).

“These findings, together with the previously reported observations that a chloride-liberal intravenous strategy can be associated with higher cost and the easy availability of cheap alternatives, suggest the need to exert prudence in the administration of fluids with supra-physiological concentrations of chloride, especially in critically ill patients with evidence of early acute renal dysfunction or at risk of acute dysfunction,” concluded senior author Rinaldo Bellomo, MD, and colleagues.

Traditional fluids used for hydration and resuscitation in the ICU, such as normal (0.9%) saline, 4% succinylated gelatin solution, or 4% albumin solution, usually include high concentrations of chloride. Several studies have shown that rapid infusion of normal saline during anesthesia and surgery inevitably leads to metabolic acidosis, which is associated with hyperchloremia. The same was not observed after administration of lactated Ringer's solution.
Related Links:
Austin Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.